Call Us: 1.800.873.5297

By

FDA Issues Class I Recall for Specific Lots of Bard LifeStent® Solo Vascular Stents due to Failure to Deploy

On September 30, 2013, the FDA issued a Class I Recall for LifeStent® Solo Vascular Stent products manufactured and distributed from November 2011 to June 13, 2012. The FDA adds that “[c]lass I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these […]

By

FDA Investigates Serious Adverse Events Reported by Patients taking Lukemia Drug Iclusig™

On October 11, 2013, the FDA issued a Drug Safety Communication informing the public that the FDA “is investigating an increasing frequency of reports of serious and life-threatening blood clots and severe narrowing of blood vessels (arteries and veins) of patients taking the leukemia chemotherapy drug Iclusig™ (ponatinib).” According to Reuters, Iclusig™ was approved by […]

By

EPA Begins Radiation Testing on Barrier Trench at Bridgeton Landfill; Activists Say This Isn’t Enough

According to The Associated Press, initial testing is underway on a trench at the Bridgeton Landfill. The trench is supposed to help prevent an underground fire at Bridgeton reaching from World War II-era nuclear waste buried 1,200 feet away (less than a quarter mile) at West Lake Landfill. Before the trench can be dug, the […]

By

Incretin-Based Diabetes Drug Lawsuits Allege Increased Risk of Pancreatic Cancer

In August 2013, the United States Judicial Panel on Multidistrict Litigation (JPML) decided to consolidate all incretin-based diabetes drug lawsuits filed in federal court – including Januvia®, Janumet®, Victoza®, and Byetta® – into a centralized Multidistrict Litigation (MDL 2452). All federally filed incretin-based diabetes drug cases have been consolidated in the United States District Court […]

By

Plaintiffs Make Another Attempt to Consolidate Lipitor® Cases in a Federal MDL

On August 8, 2013, plaintiffs’ motion to consolidate all federally filed Lipitor® cases into a central Multidistrict Litigation (MDL) was denied by the Judicial Panel on Multidistrict Litigation (JPML). The basis for the JPML’s denial of centralization was that too few Lipitor lawsuits were on file in federal court. However, another motion to consolidate all […]

By

FDA Warns that Some Antibiotics Linked to Permanent Nerve Damage

Recently, the United States Food and Drug Administration (FDA) issued a warning that fluoroquinolone antibiotics, taken by mouth or injection, carry a serious risk for permanent peripheral neuropathy. As a result, the FDA is requiring manufacturers of these antibiotics to revise their labels and medication guides to warn people of this dangerous health risk. Fluoroquinolones are among the […]

By

NuvaRing® MDL Update: Number of NuvaRing® Lawsuits Filed in Federal Court Continue to Grow

There are currently over 1,340 NuvaRing® cases pending against the manufacturers of NuvaRing®, and the number of cases filed against the manufacturers of NuvaRing® continue to increase. Since August, 61 new cases have been filed in federal court. All cases filed in federal court are consolidated in the Multidistrict Litigation In re: NuvaRing® Products Liability […]

By

Over 1,400 Lawsuits Pending in Federal Court Against Manufacturers of Pradaxa®

Since August, 79 lawsuits have been filed in federal court against the manufacturers of Pradaxa®. These lawsuits have been added to the Multidistrict Litigation In re: Pradaxa® (Dabigatran Etexilate) Products Liability Litigation (MDL 2385), which is currently pending in the United States District Court for the Southern District of Illinois before the Honorable Chief Judge […]

By

Mirena® IUD Lawsuit Update: 36 New Lawsuits Filed in Federal Multidistrict Litigation (MDL 2434)

The number of Mirena® lawsuits continues to grow with 159 lawsuits currently on file in federal court in the Multidistrict Litigation In re: Mirena® IUD Products Liability Litigation (MDL 2434), according to the most recent report issued by the Judicial Panel on Multidistrict Litigation (JPML). The Mirena® MDL is pending in the United States District Court for […]

By

Transvaginal Mesh Lawsuit Update: Over 31,000 Transvaginal Mesh Lawsuits On File in Federal Court

As of now, over 31,000 transvaginal mesh lawsuits are currently pending in federal courts – and the number of cases continues to grow. According to the most recent report released by the Judicial Panel on Multidistrict Litigation (JPML), there are six multidistrict litigations involving different transvaginal mesh device manufacturers where approximately 31,170 lawsuits are pending. Since August, […]

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.